Cargando…

Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC

Mucopolysaccharidosis type IIIC (MPSIIIC) is a severe lysosomal storage disease caused by deficiency in activity of the transmembrane enzyme heparan-α-glucosaminide N-acetyltransferase (HGSNAT) that catalyses the N-acetylation of α-glucosamine residues of heparan sulfate. Enzyme deficiency causes ab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marcó, Sara, Pujol, Anna, Roca, Carles, Motas, Sandra, Ribera, Albert, Garcia, Miguel, Molas, Maria, Villacampa, Pilar, Melia, Cristian S., Sánchez, Víctor, Sánchez, Xavier, Bertolin, Joan, Ruberte, Jesús, Haurigot, Virginia, Bosch, Fatima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Ltd 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047683/ https://www.ncbi.nlm.nih.gov/pubmed/27491071 http://dx.doi.org/10.1242/dmm.025171

Ejemplares similares

Long-Term Retinal PEDF Overexpression Prevents Neovascularization in a Murine Adult Model of Retinopathy
por: Haurigot, Virginia, et al.
Publicado: (2012)

Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapy
por: Bertolin, Joan, et al.
Publicado: (2021)

Toward a gene therapy for neurological and somatic MPSIIIA
por: Haurigot, Virginia, et al.
Publicado: (2013)

Seven-year follow-up of durability and safety of AAV CNS gene therapy for a lysosomal storage disorder in a large animal
por: Marcó, Sara, et al.
Publicado: (2021)

Early defects in mucopolysaccharidosis type IIIC disrupt excitatory synaptic transmission
por: Pará, Camila, et al.
Publicado: (2021)

Intraparenchymal convection enhanced delivery of AAV in sheep to treat Mucopolysaccharidosis IIIC
por: O’Leary, Claire, et al.
Publicado: (2023)

Characterization of the Biosynthesis, Processing and Kinetic Mechanism of Action of the Enzyme Deficient in Mucopolysaccharidosis IIIC
por: Fan, Xiaolian, et al.
Publicado: (2011)

Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT
por: Pan, Xuefang, et al.
Publicado: (2022)

The First Korean Case of Mucopolysaccharidosis IIIC (Sanfilippo Syndrome Type C) Confirmed by Biochemical and Molecular Investigation
por: Huh, Hee Jae, et al.
Publicado: (2013)

Non-syndromic retinitis pigmentosa due to mutations in the mucopolysaccharidosis type IIIC gene, heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT)
por: Haer-Wigman, Lonneke, et al.
Publicado: (2015)

Clinical characteristics and somatic burden of patients with mucopolysaccharidosis II with or without neurological involvement: An analysis from the Hunter Outcome Survey
por: Lau, Heather, et al.
Publicado: (2023)

FGF21 gene therapy as treatment for obesity and insulin resistance
por: Jimenez, Veronica, et al.
Publicado: (2018)

Treatment of Diabetes and Long-Term Survival After Insulin and Glucokinase Gene Therapy
por: Callejas, David, et al.
Publicado: (2013)

Adipose Tissue Overexpression of Vascular Endothelial Growth Factor Protects Against Diet-Induced Obesity and Insulin Resistance
por: Elias, Ivet, et al.
Publicado: (2012)

521. Investigating the Gram-Positive Selective Spectrum of Ibezapolstat, a First-in-Class DNA Polymerase IIIC (Pol IIIC) Inhibitor
por: Jahangir Alam, M, et al.
Publicado: (2022)

Neurological, neurobehavioral, and radiological alterations in patients with mucopolysaccharidosis III (Sanfilippo's syndrome) in Brazil
por: do Valle, Daniel Almeida, et al.
Publicado: (2022)

A rare case of autoimmune polyglandular syndrome type IIIc
por: Arya, Rajesh Kumar, et al.
Publicado: (2012)

Abstract: Reconstruction of Gustilo Type IIIC Injuries of the Lower Extremity
por: Abdou, Salma A., et al.
Publicado: (2018)

Mucopolysaccharidosis VI
por: Valayannopoulos, Vassili, et al.
Publicado: (2010)

Association of somatic burden of disease with age and neuropsychological measures in attenuated mucopolysaccharidosis types I, II and VI
por: Ahmed, Alia, et al.
Publicado: (2016)

Gene therapy for cross-correction of somatic organs and the CNS in mucopolysaccharidosis II in rodents and non-human primates
por: Chen, Nancy, et al.
Publicado: (2023)

Stage IIIC endometrial cancer review: Current controversies in adjuvant therapy
por: Buras, Andrea L., et al.
Publicado: (2021)

Curative treatment for stage IIIC2 cervical cancer: what to expect?
por: Mauro, Geovanne Pedro, et al.
Publicado: (2023)

Airway Abnormalities in Adult Mucopolysaccharidosis and Development of Salford Mucopolysaccharidosis Airway Score
por: Gadepalli, Chaitanya, et al.
Publicado: (2021)

Diagnosing mucopolysaccharidosis IVA
por: Wood, Timothy C., et al.
Publicado: (2013)

Mucopolysaccharidosis-Plus Syndrome
por: Vasilev, Filipp, et al.
Publicado: (2020)

Mucopolysaccharidosis Type I
por: Kubaski, Francyne, et al.
Publicado: (2020)

Hearing Loss in Mucopolysaccharidosis
por: Bicalho, Cibele Gomes, et al.
Publicado: (2021)

The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer
por: Škof, Erik, et al.
Publicado: (2016)

Lunate excision with capitohamate fusion in the treatment of stage IIIB and IIIC Kienböck's disease
por: Tahta, Mesut, et al.
Publicado: (2018)

Neo-adjuvant chemotherapy in stage IIIC potentially resectable epithelial ovarian cancer
por: Voutsadakis, Ioannis A.
Publicado: (2016)

Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy
por: Blankenstein, Stephanie A., et al.
Publicado: (2020)

Subdivision of IIIC Stage for Endometrioid Carcinoma to Better Predict Prognosis and Treatment Guidance
por: Wen, Li, et al.
Publicado: (2020)

Multimodality resection of Oliveira Type IIIC* cerebellar AVM: A distinct entity
por: Almefty, Rami, et al.
Publicado: (2022)

Topical imiquimod and cryotherapy in combination with systemic immunotherapy in unresectable stage IIIC melanoma
por: Yeh, Jennifer E., et al.
Publicado: (2022)

Clinical Observation of Fuzheng Xiaoji Granule in the Treatment of Stage IIIC Colorectal Cancer
por: Lv, Lingling, et al.
Publicado: (2022)

Prognostic model for the exemption of adjuvant chemotherapy in stage IIIC endometrial cancer patients
por: Yang, Xi-Lin, et al.
Publicado: (2022)

Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs
por: Jaén, Maria Luisa, et al.
Publicado: (2017)

Liver-directed gene therapy corrects neurologic disease in a murine model of mucopolysaccharidosis type I-Hurler
por: Jin, Xiu, et al.
Publicado: (2022)

Respiratory and sleep disorders in mucopolysaccharidosis
por: Berger, Kenneth I., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dacm443u1vqcbqoejr2uupqvd3